Cytel Adds New Clinical Software Site
Cytel, a biometrics CRO and clinical trial software provider, announced that it will be adding a new location for clinical development in Basel, Switzerland.
On Oct. 6, 2017, Cytel, a biometrics CRO and clinical trial software provider, announced that it will be adding a new location for clinical development in Basel, Switzerland.
The site, scheduled to open by the end of 2017, will hire up to 15 staff members and will join 15 other international company locations for biometrics-focused clinical research services, including Geneva, Switzerland; Paris, France; Barcelona, Spain; United Kingdom, and most recently, King of Prussia, PA in September 2017.
“Switzerland is one of the leading centers for clinical development in the world. By establishing a new office in Basel, we will be able to cement our close collaborations with customers in the region and continue to build our team of statistical programmers, biostatisticians, and data managers,” said Sébastien Gerin, senior vice president of strategy and performance at Cytel, in a company press release.
Source: Cytel
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.
